As a hematologist with 40 years experience, the results look great and worth far more then 3.5% rise. I just bought more
mghmd please drop me an email. would love to discuss crsquires at this homepage address..
not really suprising data...these are mature drugs of known efficacy...can't compete with the newer generation
of kinase inhibitors being developed...not a blockbuster...just a small niche market...
which kinase inhibitors have shown promise in AML? I'm not familiar with any. This may be the 1st small step forward in AML in the past 30 years